FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904897740> ?p ?o ?g. }

• W2904897740 endingPage "421" @default.
• W2904897740 startingPage "403" @default.
• W2904897740 abstract "Ovarian cancer stem cells (OCSCs) are sources of tumor chemoresistance and recurrence. A hypoxic microenvironment contributes to the chemoresistance of cancer stem cells (CSCs), but the underlying mechanism is not fully understood yet. Here, we show that increased HIF-2α expression is associated with enhanced stemness of OCSCs and poor outcomes in ovarian cancer patients. OVCAR-3 and CAOV-3 sphere-forming (OVCAR-3 S and CAOV-3 S) cells with OCSC-like properties showed strong resistance to adriamycin (ADR). Hypoxia (1% O2 ) induced high expression of both HIF-1α and especially HIF-2α, and increased the resistance of OVCAR-3 S and CAOV-3 S cells to ADR. Notably, treatment with ADR further increased the expression of HIF-2α, but not that of HIF-1α. Knockdown of HIF-2α expression substantially attenuated the resistance of OVCAR-3 S and CAOV-3 S cells to ADR, and the HIF-2α overexpression had the opposite effect. Furthermore, in mouse models xenografted with OCSCs, HIF-2α depletion significantly inhibited tumor growth and sensitized OCSCs to ADR in vivo. Mechanistically, HIF-2α directly promotes transcription/expression of BCRP, a gene encoding a transporter protein responsible for pumping drugs (e.g., ADR) out of cells, which in turn increases drug resistance due to increased drug transportation. Collectively, our studies reveal a novel drug-resistant mechanism in ovarian cancer by which hypoxia (and ADR treatment)-induced HIF-2α overexpression endows OCSCs with resistance to ADR by promoting BCRP expression and ADR transportation. Therefore, targeting the HIF-2α/BCRP axis holds therapeutic potential for treating drug-resistant ovarian cancer." @default.
• W2904897740 created "2018-12-22" @default.
• W2904897740 creator A5006884460 @default.
• W2904897740 creator A5015102287 @default.
• W2904897740 creator A5015518758 @default.
• W2904897740 creator A5028759261 @default.
• W2904897740 creator A5035209592 @default.
• W2904897740 creator A5043430437 @default.
• W2904897740 creator A5052556650 @default.
• W2904897740 creator A5054089830 @default.
• W2904897740 creator A5057326412 @default.
• W2904897740 creator A5061514334 @default.
• W2904897740 creator A5064055416 @default.
• W2904897740 creator A5068019929 @default.
• W2904897740 creator A5068949210 @default.
• W2904897740 creator A5072863292 @default.
• W2904897740 creator A5073474899 @default.
• W2904897740 creator A5084063375 @default.
• W2904897740 creator A5090163888 @default.
• W2904897740 date "2019-01-14" @default.
• W2904897740 modified "2023-10-16" @default.
• W2904897740 title "Hypoxia‐inducible factor‐2α directly promotes <i> <scp>BCRP</scp> </i> expression and mediates the resistance of ovarian cancer stem cells to adriamycin" @default.
• W2904897740 cites W1967063990 @default.
• W2904897740 cites W1975527793 @default.
• W2904897740 cites W1976915106 @default.
• W2904897740 cites W1977019840 @default.
• W2904897740 cites W1987003028 @default.
• W2904897740 cites W1991953785 @default.
• W2904897740 cites W2017975901 @default.
• W2904897740 cites W2027848801 @default.
• W2904897740 cites W2027852965 @default.
• W2904897740 cites W2036804836 @default.
• W2904897740 cites W2043388695 @default.
• W2904897740 cites W2050300062 @default.
• W2904897740 cites W2074437753 @default.
• W2904897740 cites W2074982201 @default.
• W2904897740 cites W2077223423 @default.
• W2904897740 cites W2085002868 @default.
• W2904897740 cites W2087744590 @default.
• W2904897740 cites W2089459615 @default.
• W2904897740 cites W2090395289 @default.
• W2904897740 cites W2090705949 @default.
• W2904897740 cites W2096234867 @default.
• W2904897740 cites W2096398695 @default.
• W2904897740 cites W2115262835 @default.
• W2904897740 cites W2119790291 @default.
• W2904897740 cites W2126712477 @default.
• W2904897740 cites W2127716534 @default.
• W2904897740 cites W2128437651 @default.
• W2904897740 cites W2142024216 @default.
• W2904897740 cites W2142478829 @default.
• W2904897740 cites W2153771223 @default.
• W2904897740 cites W2159405948 @default.
• W2904897740 cites W2163368401 @default.
• W2904897740 cites W2170785598 @default.
• W2904897740 cites W2174425170 @default.
• W2904897740 cites W2255059492 @default.
• W2904897740 cites W2272984102 @default.
• W2904897740 cites W2277854123 @default.
• W2904897740 cites W2479705541 @default.
• W2904897740 cites W2480701760 @default.
• W2904897740 cites W2507330949 @default.
• W2904897740 cites W2570618306 @default.
• W2904897740 cites W2581756437 @default.
• W2904897740 cites W2609312038 @default.
• W2904897740 cites W999871018 @default.
• W2904897740 doi "https://doi.org/10.1002/1878-0261.12419" @default.
• W2904897740 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6360369" @default.
• W2904897740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30536571" @default.
• W2904897740 hasPublicationYear "2019" @default.
• W2904897740 type Work @default.
• W2904897740 sameAs 2904897740 @default.
• W2904897740 citedByCount "38" @default.
• W2904897740 countsByYear W29048977402019 @default.
• W2904897740 countsByYear W29048977402020 @default.
• W2904897740 countsByYear W29048977402021 @default.
• W2904897740 countsByYear W29048977402022 @default.
• W2904897740 countsByYear W29048977402023 @default.
• W2904897740 crossrefType "journal-article" @default.
• W2904897740 hasAuthorship W2904897740A5006884460 @default.
• W2904897740 hasAuthorship W2904897740A5015102287 @default.
• W2904897740 hasAuthorship W2904897740A5015518758 @default.
• W2904897740 hasAuthorship W2904897740A5028759261 @default.
• W2904897740 hasAuthorship W2904897740A5035209592 @default.
• W2904897740 hasAuthorship W2904897740A5043430437 @default.
• W2904897740 hasAuthorship W2904897740A5052556650 @default.
• W2904897740 hasAuthorship W2904897740A5054089830 @default.
• W2904897740 hasAuthorship W2904897740A5057326412 @default.
• W2904897740 hasAuthorship W2904897740A5061514334 @default.
• W2904897740 hasAuthorship W2904897740A5064055416 @default.
• W2904897740 hasAuthorship W2904897740A5068019929 @default.
• W2904897740 hasAuthorship W2904897740A5068949210 @default.
• W2904897740 hasAuthorship W2904897740A5072863292 @default.
• W2904897740 hasAuthorship W2904897740A5073474899 @default.
• W2904897740 hasAuthorship W2904897740A5084063375 @default.
• W2904897740 hasAuthorship W2904897740A5090163888 @default.
• W2904897740 hasBestOaLocation W29048977401 @default.
• W2904897740 hasConcept C104317684 @default.

• next